Bietti's crystalline dystrophy
Clinical trials for Bietti's crystalline dystrophy explained in plain language.
Never miss a new study
Get alerted when new Bietti's crystalline dystrophy trials appear
Sign up with your email to follow new studies for Bietti's crystalline dystrophy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a single injection save sight in a rare retinal disease?
Cure OngoingThis early-stage trial is testing whether a gene therapy called NGGT001, injected under the retina, is safe and tolerable for people with Bietti's crystalline dystrophy, a rare inherited condition that causes progressive vision loss. The study enrolls about 11 adults with a confi…
Matched conditions: BIETTI'S CRYSTALLINE DYSTROPHY
Early phase 1 • Sponsor: Xiamen Ophthalmology Center Affiliated to Xiamen University • Aim: Cure
Last updated Aug 19, 2026 00:00 UTC
-
One-Time gene injection aims to halt rare eye disease
Disease control OngoingThis study tests a single injection of ZVS101e, a gene therapy that delivers a working copy of the CYP4V2 gene directly into the retina. It is for adults with Bietti's crystalline dystrophy, a rare inherited condition that leads to progressive vision loss. The trial will check wh…
Matched conditions: BIETTI'S CRYSTALLINE DYSTROPHY
Phase 1/2 • Sponsor: Chigenovo Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC